Showing results (251-260 of 348) with videos related to

Sort By:
Pageof 35
Nature Communications|July 2, 2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseLaia Montoliu-Gaya, Shijia Bian, Eric B Dammer, et al.
Ebiomedicine|September 19, 2024
Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinicAmanda Cano, María Capdevila, Raquel Puerta, et al.
Brain : a Journal of Neurology|April 17, 2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuumBenjamin J Buehner, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's diseaseStephanie M Grasso, Wenfu Bao, Sonia Karin Marqués-Kiderle, et al.
Frontiers in Aging Neuroscience|July 6, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversionConcepcion Padilla, Sara E Zsadanyi, Irina Aragón, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Neurology|June 17, 2026
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very OldChiara Ceriello, Olga H Torres, Sara Rubio-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 29, 2017
Cortical microstructural changes along the Alzheimer's disease continuumVictor Montal, Eduard Vilaplana, Daniel Alcolea, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Nature Aging|April 28, 2023
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panelsMarta Del Campo, Carel F W Peeters, Erik C B Johnson, et al.
Pageof 35